Revised Schedule M · WHO-GMP · EU-GMP · US FDA — on site and remotely
Not every task requires a consultant standing on the shop floor, and not every task can be done from a desk. Work is arranged in whichever form suits it — most assignments use a combination.
The position is stated plainly before we leave the site — not weeks later in a document that has been softened on the way.
A walk through the plant, an examination of records against what the rooms and equipment actually show, and a direct discussion with the department heads. The position is stated plainly before we leave the site, not weeks later in a document.
A clause-wise gap register against the standard that will actually be applied, each observation ranked by risk, with photographic evidence where a description would not carry the point.
A bridging roadmap separating what must be corrected to remain licensed from what should follow and what can reasonably wait — with layout revisions, sequence, internal owners and target dates identified.
Documents drafted, layouts revised, qualification and validation executed, and your people trained alongside the work rather than after it, so the system is understood by those who must defend it.
A full mock inspection before the regulator or the customer arrives, followed by support in drafting responses and closing observations to the satisfaction of the authority.
Compliance budgets are finite. These six rules decide what is done first, what is reworked rather than replaced, and what can reasonably wait.
Effort and money go where a licence, a batch or a market is genuinely at stake. Everything else takes its turn.
Existing walls, utilities and equipment are reworked and re-qualified before new capital is committed.
Upgradation is staged so that it can be funded and absorbed without stopping the plant.
A single, coherent set of records is built to satisfy every authority and customer that will read it.
Your team is trained to run and defend the system, so the assignment ends and the compliance does not.
Indicators show whether what was spent actually moved the performance of the plant.
These are terms of engagement, not sentiments. Each one is capable of being held to.
Formulations, layouts, records and commercial information seen during an assignment are treated as confidential, and non-disclosure undertakings are signed as a matter of course.
No commission, referral or commercial interest is taken from any equipment supplier, instrument maker or vendor recommended — advice follows what the plant needs, not what a supplier is selling.
Assessment and upgradation work is planned around the production schedule and sequenced so that the plant keeps running.
Wherever possible the site’s own team carries out the work under guidance and review, so that ownership, competence and confidence remain in-house.
A single visit establishes where a site stands against the standard it will actually be judged by, what must change in the layout, the systems and the records, and in what order those changes should be made. Everything after that is a matter of sequence and execution.